{"id":"NCT02149524","sponsor":"Samsung Bioepis Co., Ltd.","briefTitle":"A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer","officialTitle":"A Phase III Randomised, Double-Blind, Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity Between SB3 (Proposed Trastuzumab Biosimilar) and Herceptin® in Women With Newly Diagnosed HER2 Positive Early or Locally Advanced Breast Cancer in Neoadjuvant Setting","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-04","primaryCompletion":"2016-03","completion":"2017-02","firstPosted":"2014-05-29","resultsPosted":"2018-10-24","lastUpdate":"2018-10-24"},"enrollment":875,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["HER2 Positive Early or Locally Advanced Breast Cancer"],"interventions":[{"type":"DRUG","name":"Herceptin (trastuzuamb)","otherNames":["Herceptin"]},{"type":"DRUG","name":"SB3 (proposed trastuzumab biosimilar)","otherNames":[]}],"arms":[{"label":"Herceptin (trastuzumab)","type":"ACTIVE_COMPARATOR"},{"label":"SB3 (proposed trastuzumab biosimilar)","type":"EXPERIMENTAL"}],"summary":"A Phase III Randomised, Double-Blind, Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity between SB3 (proposed trastuzumab biosimilar) and Herceptin® in Women with Newly Diagnosed HER2 Positive Early or Locally Advanced Breast Cancer in Neoadjuvant Setting","primaryOutcome":{"measure":"The Pathologic Complete Response (pCR) Rate of the Primary Breast Tumour","timeFrame":"Week 24","effectByArm":[{"arm":"Herceptin (Trastuzumab)","deltaMin":42,"sd":null},{"arm":"SB3 (Proposed Trastuzumab Biosimilar)","deltaMin":51.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":15},"locations":{"siteCount":1,"countries":["Czechia"]},"refs":{"pmids":["29448072","29373094"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":58,"n":438},"commonTop":["Alopecia","Neutropenia","Nausea","Leukopenia","Anaemia"]}}